ZyVersa Therapeutics's total assets for Q4 2024 were $20.60B, an increase of 105951.76% from the previous quarter. ZVSA total liabilities were $12.08B for the fiscal quarter, a 97369.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.